| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Departments of Ophthalmology and Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland; and 2 GenVec Inc., Gaithersburg, Maryland.
PURPOSE. Several pharmacologic treatments have been shown to reduce ocular neovascularization when administered before the onset of angiogenic stimuli, but none have been shown to cause regression of already established ocular neovascularization. In this study, the authors tested the effect of adenoviral vectored pigment epithelium-derived factor (PEDF) gene transfer on established neovascularization in transgenic mice with expression of vascular endothelial growth factor (VEGF) in photoreceptors (rho/VEGF mice) and in a model of choroidal neovascularization.
METHODS. Two weeks after the onset of VEGF transgene expression in rho/VEGF mice or 2 weeks after laser-induced rupture of Bruch’s membrane in wild-type mice, subgroups of mice were killed, and the baseline amount of neovascularization was measured by image analysis. The remainder of the mice received an intravitreous or subretinal injection of adenoviral vector containing a PEDF expression construct (AdPEDF.11) or control vector (AdNull.11).
RESULTS. Seven days after injection in rho/VEGF mice or 10 days after injection in the choroidal neovascularization model, the amount of neovascularization in AdPEDF.11-injected eyes was significantly less than the baseline level, indicating that regression of neovascularization had occurred. There was TUNEL staining within choroidal neovascular lesions in eyes injected with AdPEDF.11. Eyes given a subretinal injection of AdNull.11 had TUNEL-positive cells in the retina, but none within areas of choroidal neovascularization.
CONCLUSIONS. These data indicate that increased expression of PEDF causes regression of ocular neovascularization by promoting apoptosis of cells within neovascular lesions and possibly represents a new treatment paradigm for patients with established ocular neovascularization.
This article has been cited by other articles:
|
|
 |
|
  I. A. Bhutto, K. Uno, C. Merges, L. Zhang, D. S. McLeod, and G. A. Lutty Reduction of Endogenous Angiogenesis Inhibitors in Bruch's Membrane of the Submacular Region in Eyes With Age-Related Macular Degeneration Arch Ophthalmol, May 1, 2008; 126(5): 670 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Y. Park, R. S. Chuck, M. Cano, M. Yew, V. Nguyen, J. Parker, K. Mori, and P. L. Gehlbach Periocular Triamcinolone Enhances Intraocular Gene Expression after Delivery by Adenovirus Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 399 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Morris, F. Imrie, A.-M. Armbrecht, and B. Dhillon Age-related macular degeneration and recent developments: new hope for old eyes? Postgrad. Med. J., May 1, 2007; 83(979): 301 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Paskowitz, K. M. Donohue-Rolfe, H. Yang, D. Yasumura, M. T. Matthes, K. Hosseini, C. M. Graybeal, G. Nune, M. A. Zarbin, M. M. LaVail, et al. Neurotrophic Factors Minimize the Retinal Toxicity of Verteporfin Photodynamic Therapy Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 430 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Notari, V. Baladron, J. D. Aroca-Aguilar, N. Balko, R. Heredia, C. Meyer, P. M. Notario, S. Saravanamuthu, M.-L. Nueda, F. Sanchez-Sanchez, et al. Identification of a Lipase-linked Cell Membrane Receptor for Pigment Epithelium-derived Factor J. Biol. Chem., December 8, 2006; 281(49): 38022 - 38037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Maik-Rachline and R. Seger Variable phosphorylation states of pigment-epithelium-derived factor differentially regulate its function Blood, April 1, 2006; 107(7): 2745 - 2752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Penn, G. W. McCollum, J. M. Barnett, X. Q. Werdich, K. A. Koepke, and V. S. Rajaratnam Angiostatic Effect of Penetrating Ocular Injury: Role of Pigment Epithelium-Derived Factor Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 405 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Amaral, R. N. Fariss, M. M. Campos, W. G. Robison Jr, H. Kim, R. Lutz, and S. P. Becerra Transscleral-RPE Permeability of PEDF and Ovalbumin Proteins: Implications for Subconjunctival Protein Delivery Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4383 - 4392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Chevez-Barrios, M. Chintagumpala, W. Mieler, E. Paysse, M. Boniuk, C. Kozinetz, M. Y. Hurwitz, and R. L. Hurwitz Response of Retinoblastoma With Vitreous Tumor Seeding to Adenovirus-Mediated Delivery of Thymidine Kinase Followed by Ganciclovir J. Clin. Oncol., November 1, 2005; 23(31): 7927 - 7935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Anzai, S. Yoneya, P. L. Gehlbach, D. Imai, L. L. Wei, and K. Mori Laser Photocoagulation and, to a Lesser Extent, Photodynamic Therapy Target and Enhance Adenovirus Vector-Mediated Gene Transfer in the Rat Retina Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3883 - 3891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. e Silva, Y. Saishin, Y. Saishin, H. Akiyama, S. Kachi, S. Aslam, B. Rogers, T. Deering, Y. Y. Gong, S. F. Hackett, et al. Suppression and Regression of Choroidal Neovascularization by Polyamine Analogues Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3323 - 3330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Filleur, K. Volz, T. Nelius, Y. Mirochnik, H. Huang, T. A. Zaichuk, M. S. Aymerich, S. P. Becerra, R. Yap, D. Veliceasa, et al. Two Functional Epitopes of Pigment Epithelial-Derived Factor Block Angiogenesis and Induce Differentiation in Prostate Cancer Cancer Res., June 15, 2005; 65(12): 5144 - 5152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kanda, Y. Mochizuki, T. Nakamura, Y. Miyata, T. Matsuyama, and H. Kanetake Pigment epithelium-derived factor inhibits fibroblast-growth-factor-2-induced capillary morphogenesis of endothelial cells through Fyn J. Cell Sci., March 1, 2005; 118(5): 961 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J K Luttrull, D C Musch, and M A Mainster Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema Br. J. Ophthalmol., January 1, 2005; 89(1): 74 - 80. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Apte, R. A. Barreiro, E. Duh, O. Volpert, and T. A. Ferguson Stimulation of Neovascularization by the Anti-angiogenic Factor PEDF Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4491 - 4497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Franklin, T. L. Jetton, C. L. Kuchemann, S. R. Russell, and E. C. Kohn CAI Is a Potent Inhibitor of Neovascularization and Imparts Neuroprotection in a Mouse Model of Ischemic Retinopathy Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3756 - 3766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Zarbin Current Concepts in the Pathogenesis of Age-Related Macular Degeneration Arch Ophthalmol, April 1, 2004; 122(4): 598 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ida, T. Tobe, H. Nambu, M. Matsumura, M. Uyama, and P. A. Campochiaro RPE Cells Modulate Subretinal Neovascularization, but Do Not Cause Regression in Mice with Sustained Expression of VEGF Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5430 - 5437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sengupta, S. Caballero, R. N. Mames, J. M. Butler, E. W. Scott, and M. B. Grant The Role of Adult Bone Marrow-Derived Stem Cells in Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4908 - 4913. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
